Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 24, Number 4—April 2018
Research Letter

Intensive Care Admissions for Severe Chikungunya Virus Infection, French Polynesia

Article Metrics
citations of this article
EID Journal Metrics on Scopus
Adrien KoeltzComments to Author , Stephane Lastere, and Sylvain Jean-Baptiste
Author affiliations: Taaone Hospital, Papeete, French Polynesia (A. Koeltz, S. Lastere); Bichat Hospital, Paris, France (S. Jean-Baptiste)

Cite This Article


During the 2014–2015 chikungunya outbreak in French Polynesia, 64 patients with confirmed chikungunya virus infection were admitted into intensive care. Sixty-three were nonpregnant adults; 11 had an atypical form, 21 had severe sepsis or septic shock, and 18 died. These findings indicate that critical illness frequently complicates the course of chikungunya virus infection.

The first case of chikungunya virus (CHIKV) infection in French Polynesia (Tahiti) was diagnosed in May 2014; it was imported from Guadeloupe Island in the Caribbean (1). During the outbreak that developed during October 2014–March 2015, ≈25% of the local population (272,000 residents) became infected with CHIKV (2). French Polynesia has 2 potential mosquito vectors for CHIKV: Aedes aegypti and A. polynesiensis. Phylogenic analysis showed that the French Polynesia strain of CHIKV belongs to the Asian lineage and is closely related to the strain collected in Guadeloupe and the British Virgin Islands in 2014, showing 99.9% homology with that strain (3). To describe patient characteristics and clinical courses of chikungunya patients in French Polynesia during 2014–2015, we retrospectively reviewed the medical files of all patients with documented CHIKV infection.

CHIKV infection was defined by the association of compatible symptoms of fever and arthralgia and positive IgM serology or positive blood reverse transcription PCR (RT-PCR). We defined types of CHIKV infection as follows: 1) common form (i.e., only fever or arthralgia); 2) atypical form (i.e., involvement of >1 organ systems); and 3) severe form (i.e., failure of >1 organ systems or admission to an intensive care unit [ICU]).

We used standard definitions for organ system failures and severe sepsis shock (4). Organ failures were defined by a Sequential Organ Failure Assessment score >3 for each organ. Encephalitis was defined in accordance with Consensus Statement of the International Encephalitis Consortium criteria (5) and myocarditis in accordance with Position Statement of the European Society of Cardiology criteria (6).

During the outbreak, CHIKV was confirmed in 63 adults and one 11-year-old girl (Table). Forty-two patients had positive results for blood RT-PCR, and 22 had positive results for IgM serology. Virus load in serum was high; median load was 7.52 log10 copies/mL (interquartile range 3.47–9.39 log10 copies/mL). Of 5 patients with encephalitis symptoms, 3 had positive results for cerebrospinal fluid RT-PCR.

Forty-nine (76%) patients had a preexisting disease, 33 (51%) required invasive mechanical ventilation, 40 (62%) were in shock and needed vasoactive drugs, and 30 (46%) required renal replacement therapy. The ICU death rate for chikungunya was 28%, slightly higher than the usual 22% ICU death rate (A. Koeltz, unpub. data). Five patients had encephalitis, 2 had myocarditis, and 4 had Guillain-Barré syndrome (GBS). Fifty-five patients had a severe form of chikungunya, and 21 had illness consistent with the case definition for severe sepsis; for 2 patients, no other cause for GBS than CHIKV was identified. Two patients had CHIKV–leptospirosis co-infection, and 1 had CHIKV–dengue virus co-infection. Among the 55 patients who had the severe form of chikungunya, 17 had exacerbations of a chronic condition.

Chikungunya can be complicated by severe multiple organ failure and lead to death either from exacerbation of a preexisting disease or by severe atypical infection. Severe septic shock directly attributable to CHIKV was reported during the 2014 outbreak (7,8), and these reports seem consistent with our study (2 cases). This finding could be explained by the fact that chikungunya induces lymphopenia.

Neurologic complications of arbovirus infections are well documented, as illustrated by the high incidence of GBS reported during French Polynesia’s outbreak of Zika virus (42 cases) (9). In our study, we observed 4 severe cases of GBS, and 10 GBS cases were managed in the hospital during the outbreak; GBS incidence was 4 times higher than usually observed in this hospital.

The most severe atypical complication in our study was myocarditis (2 cases), which had a 100% case-fatality rate. These deaths included an 11-year-old child and a 56-year-old woman without preexisting disease.

Our findings indicate that critical illness frequently complicates the course of CHIKV infection. Hospitals in chikungunya-endemic areas should be aware of the potential for increases in the number of ICU admissions during outbreaks.

Dr. Koeltz is a cardiac anesthesiologist at Bichat Claude-Bernard University Hospital in Paris. His research interests include infectious diseases in tropical areas.



We thank Thomas Koeltz for his review.



  1. Nhan  T-X, Claverie  A, Roche  C, Teissier  A, Colleuil  M, Baudet  J-M, et al. Chikungunya virus imported into French Polynesia, 2014. Emerg Infect Dis. 2014;20:17734. DOIPubMedGoogle Scholar
  2. Nhan  TX, Musso  D. The burden of chikungunya in the Pacific. Clin Microbiol Infect. 2015;21:e478. DOIPubMedGoogle Scholar
  3. Aubry  M, Teissier  A, Roche  C, Richard  V, Yan  AS, Zisou  K, et al. Chikungunya outbreak, French Polynesia, 2014. Emerg Infect Dis. 2015;21:7246. DOIPubMedGoogle Scholar
  4. Dellinger  RP, Carlet  JM, Masur  H, Gerlach  H, Calandra  T, Cohen  J, et al.; Surviving Sepsis Campaign Management Guidelines Committee. Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Crit Care Med. 2004;32:858–73. [Erratum in Crit Care Med. 2004;32:1448]. Erratum in Crit Care Med. 2004;32:216970.
  5. Venkatesan  A, Tunkel  AR, Bloch  KC, Lauring  AS, Sejvar  J, Bitnun  A, et al.; International Encephalitis Consortium. Case definitions, diagnostic algorithms, and priorities in encephalitis: consensus statement of the international encephalitis consortium. Clin Infect Dis. 2013;57:111428. DOIPubMedGoogle Scholar
  6. Caforio  AL, Pankuweit  S, Arbustini  E, Basso  C, Gimeno-Blanes  J, Felix  SB, et al. Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J. 2013;34:2636–48, 2648a–2648d.
  7. Torres  JR, Castro  JS, Rodríguez  L, Saravia  V, Arvelaez  J, Ríos-Fabra  A, et al.; Leopoldo Códova G. Chikungunya fever: Atypical and lethal cases in the Western hemisphere: A Venezuelan experience. IDCases. 2014;2:610. DOIPubMedGoogle Scholar
  8. Rollé  A, Schepers  K, Cassadou  S, Curlier  E, Madeux  B, Hermann-Storck  C, et al. Severe sepsis and septic shock associated with chikungunya virus infection, Guadeloupe, 2014. Emerg Infect Dis. 2016;22:8914. DOIPubMedGoogle Scholar
  9. Cao-Lormeau  V-M, Blake  A, Mons  S, Lastère  S, Roche  C, Vanhomwegen  J, et al. Guillain-Barré Syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control study. Lancet. 2016;387:15319. DOIPubMedGoogle Scholar




Cite This Article

DOI: 10.3201/eid2404.161536

Table of Contents – Volume 24, Number 4—April 2018

EID Search Options
presentation_01 Advanced Article Search – Search articles by author and/or keyword.
presentation_01 Articles by Country Search – Search articles by the topic country.
presentation_01 Article Type Search – Search articles by article type and issue.



Please use the form below to submit correspondence to the authors or contact them at the following address:

Adrien Koeltz, Department of Anesthesiology and Intensive Care, Centre Hospitalier Universitaire Bichat Claude-Bernard, 46 Rue Henri Huchard, 75018 Paris, France

Send To

10000 character(s) remaining.


Page created: March 16, 2018
Page updated: March 16, 2018
Page reviewed: March 16, 2018
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.